Navigation Links
Genesis Biopharma Announces Letter to Shareholders Posted to Website
Date:8/30/2011

irmatory trial for approval as a first line treatment in this indication.  In addition, the Company plans to expand the development of this innovative platform technology with pilot studies using its ACT to treat breast, ovarian and colorectal cancers. 

Genesis Biopharma is a led by a seasoned management team and world-class board of directors, with participation from a prestigious scientific and medical advisory board.  For more information about the company, visit www.genesis-biopharma.com.

Forward-Looking Statements

The foregoing announcement contains forward-looking statements that can be identified by such terminology as "expects", "hopes", "potential", "suggests", "bodes", "may", "should", "could", or similar expressions.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements.  In particular, management's expectations regarding future research, development and/or commercial results could be affected by, among other things, uncertainties relating to clinical trials and product development; availability of future financing; unexpected regulatory delays or government regulation generally; the company's ability to obtain or maintain patent and other proprietary intellectual property protection; and competition in general.  Forward-looking statements speak only as of the date they are made.  The company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.


'/>"/>
SOURCE Genesis Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao
2. Mummy News: Genesis Medical Imaging Mobile CT Scan Unit Helps Chicagos Field Museum Discover Ancient Secrets
3. Genesis Biopharma to Hold Business Update Conference Call on June 29
4. ThermoGenesis Announces Webcast of Presentation at OnemedForum Conference
5. Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes
6. Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
7. CryoLife Announces Completion of Acquisition of Cardiogenesis
8. CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation
9. ThermoGenesis Reports Third Quarter Fiscal 2011 Results; Major Progress Achieved in China & India
10. Cardiogenesis Reports First Quarter 2011 Results
11. CryoLife Completes Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014 Kiromic, LLC, a ... Kent Hance , the former chancellor of Texas Tech ... as chancellor in July 2014, after raising $1.2 billion for ... Kent Hance , the most successful chancellor in the ... not only as an investor, but also as our new ...
(Date:9/19/2014)... , September 19, 2014 ... by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, ... (Hospitals), Advanced technologies - Global Forecast to 2019" ... poised to reach $19,786.3 Million by 2019 from ... 6.8% from 2014 to 2019. Browse ...
(Date:9/19/2014)... , Sept. 19, 2014  4WEB Medical announces the ... foot and ankle osteotomy implants on the market ... Society annual meeting in Chicago . ... of a surgeon,s osteotomy needs with 74 size options included ... had smaller offerings of only 15 to 18 implant sizes, ...
Breaking Medicine Technology:Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 44WEB Medical Unveils 3D-Printed Osteotomy Truss System 2
... (NASDAQ: THOR ), a world leader in ... restore failing hearts, said today revenues for the second ... increase over revenues of $95.1 million in the second ... of fiscal 2010 exclude contributions from the company,s International ...
... Inc. (NASDAQ: CADX ), a biopharmaceutical company ... for use in the hospital setting, today reported financial ... 30, 2011. Cadence commercially launched OFIRMEV® (acetaminophen) ... to be approved in the U.S., in January 2011. ...
Cached Medicine Technology:Thoratec Reports Second Quarter Revenue Increase of 17 Percent 2Thoratec Reports Second Quarter Revenue Increase of 17 Percent 3Thoratec Reports Second Quarter Revenue Increase of 17 Percent 4Thoratec Reports Second Quarter Revenue Increase of 17 Percent 5Thoratec Reports Second Quarter Revenue Increase of 17 Percent 6Thoratec Reports Second Quarter Revenue Increase of 17 Percent 7Thoratec Reports Second Quarter Revenue Increase of 17 Percent 8Thoratec Reports Second Quarter Revenue Increase of 17 Percent 9Thoratec Reports Second Quarter Revenue Increase of 17 Percent 10Thoratec Reports Second Quarter Revenue Increase of 17 Percent 11Thoratec Reports Second Quarter Revenue Increase of 17 Percent 12Thoratec Reports Second Quarter Revenue Increase of 17 Percent 13Thoratec Reports Second Quarter Revenue Increase of 17 Percent 14Thoratec Reports Second Quarter Revenue Increase of 17 Percent 15Thoratec Reports Second Quarter Revenue Increase of 17 Percent 16Thoratec Reports Second Quarter Revenue Increase of 17 Percent 17Thoratec Reports Second Quarter Revenue Increase of 17 Percent 18Thoratec Reports Second Quarter Revenue Increase of 17 Percent 19Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results 2Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results 3Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results 4Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results 5Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results 6Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results 7Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results 8
(Date:9/19/2014)... Hastings and Hastings, a discount accident lawyer in Phoenix, Arizona, ... number of visitors to its new Phoenix personal injury website. ... as well as auto accident cases and slip & fall ... others. Having served the state of Arizona for over 30 ... when it comes to dedicated and focused personal injury legal ...
(Date:9/19/2014)... 2014 Boston Scientific Corp. has moved ... http://www.transvaginalmeshlawsuithelp.com/ ) that is scheduled to go to ... LLP reports. According to a Motion filed ... asserts that claims involving its Solyx pelvic mesh device ... Code, a section of which shields manufacturers from ...
(Date:9/19/2014)... 2014 (HealthDay News) -- Although there is mounting ... most middle-aged and older adults in the United ... according to new research. Less than one-quarter ... set by the Department of Health and Human ... essential for promoting health and fitness and staying ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Lipitor lawsuits ... caused some patients to develop Type 2 diabetes continue ... underway in U.S. District Court, District of South Carolina, ... issued on September 12, 2014, discovery is underway and ... report noted that Pfizer, Inc., the manufacturer of Lipitor, ...
(Date:9/19/2014)... In partnership with Raw Beauty NYC, OC healthcare ... project’s social media efforts. StudioPMG is honored to be a ... of beauty as it applies to disabled women. , ... Baer and Vanessa Silberman, who wanted to create a photo ... Dixon, Wendy Crawford, Susan Solman and Sabrina Cohen later joined ...
Breaking Medicine News(10 mins):Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2Health News:Transvaginal Mesh Lawsuit Defendant Moves For Summary Judgment in Case Scheduled for Upcoming Texas Trial, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit Defendant Moves For Summary Judgment in Case Scheduled for Upcoming Texas Trial, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit Defendant Moves For Summary Judgment in Case Scheduled for Upcoming Texas Trial, Bernstein Liebhard LLP Reports 4Health News:Adults Over 45 Not Meeting U.S. Muscle Strengthening Guidelines, Study Says 2Health News:Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:OC Healthcare Agency StudioPMG Partners with The Raw Beauty Project ™ NYC 2014 2
... ... Wins ,Wharton Business Plan Competition Michelson Grand Prize with ,Device that Helps Osteoporosis ... for Co-eds, , ... Philadelphia, PA (PRWEB) April 29, 2010 -- The Wharton School of ...
... new gene expression study in embryonic stem cells has uncovered ... than once thought but is also heavily regulated by the ... in the April 30th edition of Cell , a ... the transcription process that serves to regulate expression of as ...
... ... ... version of Greenpeace’s Cool IT Leaderboard (1) reveals how some global IT companies are leading ... energy use, while others seem unable to decide if IT climate solutions are a significant ...
... mutation impacts how the brain communicates with limbs, researcher says ... that causes a phenomenon known as mirror movements has been ... unable to move one side of their body without moving ... right hand, the same movement occurs unintentionally in the left ...
... ... , ... NJ (Vocus) -- Volkmann, a market leader in vacuum conveying, introduces its “No-Tip ... flow issues involved when transferring powders, granules, pellets, capsules, tablets and other bulk ...
... Mice, frogs, and E. coli are standard organisms ... in part to technical advances, the reduced costs of genome ... of organisms used for research has greatly expanded. Scientists ... might better address their specific research question. Eighteen diverse ...
Cached Medicine News:Health News:Wharton Business Plan Competition Michelson Grand Prize Winners Announced 2Health News:Wharton Business Plan Competition Michelson Grand Prize Winners Announced 3Health News:Embryonic stem cells reveal oncogene's secret growth formula 2Health News:IT Leaderboard Showcases Growing Divide Between Talk and Action on Developing Climate Solutions 2Health News:IT Leaderboard Showcases Growing Divide Between Talk and Action on Developing Climate Solutions 3Health News:IT Leaderboard Showcases Growing Divide Between Talk and Action on Developing Climate Solutions 4Health News:Scientists Find Cause of Involuntary Mirror Movements 2
... The Laserex Ultra Q is the fundamental ... cavity optimizes energy delivery and provides 2855% less ... to 2.54.0 mJs in contemporary systems. This ... dramatically reduces the risk of IOL pitting. ...
... The Ultrasonix 500 is a high-end, mobile ... based architecture provides a tremendous amount of ... contrast and resolution. Ultrasonix imaging systems ... modes including B, B/M, Pulsed Doppler, Color ...
Protects the eye during or after surgery or trauma. Clear window dressing. Protects the eye allowing the patient to see....
Protects the eye during or after surgery or trauma. 8mm diameter, lint free keeps cornea moist. Protects retina from operating microscope light rays....
Medicine Products: